Antares Pharma, Inc. Reports Second Quarter 2013 Operating and Financial Results

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Antares Pharma, Inc. (NASDAQ: ATRS) today reported operating and financial results for the second quarter ended June 30, 2013.

Quarter and Recent Highlights

•OTREXUP™ development program is on track with anticipated PDUFA date of October 14, 2013.

•Granted product specific U.S. patent 8,480,631 for OTREXUP™.

Hey, check out all the research scientist jobs. Post your resume today!
MORE ON THIS TOPIC